Delivery Order SPE2DB22D9225-SPE2DB24FR8FF

Award Date 7/25/24
Potential Completion Date 7/26/24
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,911.80 contract is for the delivery of Cosentyx Unoready 300 mg pens to the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of October 23, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This federal contract award is for the delivery of Cosentyx (secukinumab) 300 mg pens to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense (DoD). The contract, valued at $3,382.36, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with no set-aside designation, running from the award date of July 30, 2024 through the ultimate...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,382.36 firm fixed-price contract is for the delivery of 4565434185 COSENTYX UNOREADY 300 MG PEN 2ML, a specialized prescription medication. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $22,461.51, is for the delivery of Cosentyx 300mg dose prefilled syringes. The contract does not have a set-aside designation and is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $5,100.90 delivery order is for the pharmaceutical product "COSENTYX SNRDY 300MG DOSE-2PENML" and has a completion date of July 30, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the supply of Cosentyx (secukinumab) 300 mg dose autoinjectors, a specialized biologic medication used to treat certain medical conditions. The contract is a firm fixed-price delivery order with a ceiling value of $9,162.16 and a period of performance through March 13, 2024. This award is part of a larger...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $34,859.08 contract is for the supply of Cosentyx, a prescription medication, to support the medical needs of military healthcare facilities. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery orders for...
This is a $1,521.95 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The order is for 4,564,309,800 units of the medication COSENTYX UNOREADY 300 MG PEN 2ML. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC allows the DLA to issue firm...
This is a $43,583.14 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of the pharmaceutical product COSENTYX SNRDY 300MG DOSE-2PENML. The delivery order was issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA valued up to $499,999,999, which allows the DLA to order a comprehensive range of pharmaceutical items to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, worth $1,691.18, is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a specialized pharmaceutical product. This contract is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract...
  • SPE2DB22D9225
    Indefinite Delivery Contract
  • SPE2DB22D9225-SPE2DB24FR8FF
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,382.36, is for the delivery of Cosentyx (secukinumab) 300 mg pens to support the medical supply needs of military healthcare facilities.

DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical items, including both common and specialized drugs and medical supplies, to fulfill the recurring medical requirements of Department of Defense (DoD) healthcare facilities worldwide. The current delivery order is not designated as a set-aside contract.

Generated 10/27/24, 3:41 AM